| Product Code: ETC6013061 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Afghanistan Neuroblastoma Market Overview |
3.1 Afghanistan Country Macro Economic Indicators |
3.2 Afghanistan Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Afghanistan Neuroblastoma Market - Industry Life Cycle |
3.4 Afghanistan Neuroblastoma Market - Porter's Five Forces |
3.5 Afghanistan Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Afghanistan Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Afghanistan Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Afghanistan Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuroblastoma cases in Afghanistan |
4.2.2 Growing awareness and early diagnosis of neuroblastoma |
4.2.3 Advancements in medical technology and treatment options for neuroblastoma |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities in Afghanistan |
4.3.2 High treatment costs associated with neuroblastoma care |
4.3.3 Lack of healthcare infrastructure and resources in remote areas |
5 Afghanistan Neuroblastoma Market Trends |
6 Afghanistan Neuroblastoma Market, By Types |
6.1 Afghanistan Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Afghanistan Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Afghanistan Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Afghanistan Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Afghanistan Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Afghanistan Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Afghanistan Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Afghanistan Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Afghanistan Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Afghanistan Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Afghanistan Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Afghanistan Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Afghanistan Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Afghanistan Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Afghanistan Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Afghanistan Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Afghanistan Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Afghanistan Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Afghanistan Neuroblastoma Market Import-Export Trade Statistics |
7.1 Afghanistan Neuroblastoma Market Export to Major Countries |
7.2 Afghanistan Neuroblastoma Market Imports from Major Countries |
8 Afghanistan Neuroblastoma Market Key Performance Indicators |
8.1 Number of neuroblastoma screening programs implemented |
8.2 Percentage increase in early-stage neuroblastoma diagnoses |
8.3 Adoption rate of innovative neuroblastoma treatment technologies |
9 Afghanistan Neuroblastoma Market - Opportunity Assessment |
9.1 Afghanistan Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Afghanistan Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Afghanistan Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Afghanistan Neuroblastoma Market - Competitive Landscape |
10.1 Afghanistan Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Afghanistan Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here